rs2452658

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The ENST00000635775.1(ENSG00000283674):​n.1973-12536T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.51 ( 2040 hom., cov: 83)
Failed GnomAD Quality Control

Consequence

ENSG00000283674
ENST00000635775.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0690

Publications

1 publications found
Variant links:
Genes affected
FAM66A (HGNC:30444): (family with sequence similarity 66 member A)
FAM86B2-DT (HGNC:48726): (FAM86B2 divergent transcript)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000635775.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000635775.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FAM86B2-DT
NR_040092.1
n.1337-14285A>G
intron
N/A
LOC729732
NR_047662.2
n.1996-12536T>C
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ENSG00000283674
ENST00000635775.1
TSL:2
n.1973-12536T>C
intron
N/A
ENSG00000283674
ENST00000641618.1
n.587+29227T>C
intron
N/A
ENSG00000283674
ENST00000641839.1
n.684-40344T>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.508
AC:
74213
AN:
145962
Hom.:
2037
Cov.:
83
show subpopulations
Gnomad AFR
AF:
0.508
Gnomad AMI
AF:
0.515
Gnomad AMR
AF:
0.517
Gnomad ASJ
AF:
0.510
Gnomad EAS
AF:
0.571
Gnomad SAS
AF:
0.520
Gnomad FIN
AF:
0.508
Gnomad MID
AF:
0.513
Gnomad NFE
AF:
0.501
Gnomad OTH
AF:
0.509
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
0.508
AC:
74266
AN:
146060
Hom.:
2040
Cov.:
83
AF XY:
0.510
AC XY:
36420
AN XY:
71410
show subpopulations
African (AFR)
AF:
0.508
AC:
20327
AN:
40020
American (AMR)
AF:
0.517
AC:
7659
AN:
14824
Ashkenazi Jewish (ASJ)
AF:
0.510
AC:
1700
AN:
3332
East Asian (EAS)
AF:
0.571
AC:
2900
AN:
5080
South Asian (SAS)
AF:
0.520
AC:
2424
AN:
4666
European-Finnish (FIN)
AF:
0.508
AC:
5085
AN:
10018
Middle Eastern (MID)
AF:
0.514
AC:
146
AN:
284
European-Non Finnish (NFE)
AF:
0.501
AC:
32526
AN:
64902
Other (OTH)
AF:
0.509
AC:
1038
AN:
2038
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.541
Heterozygous variant carriers
0
1753
3505
5258
7010
8763
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
866
1732
2598
3464
4330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.502
Hom.:
232

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
7.1
DANN
Benign
0.73
PhyloP100
-0.069

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2452658;
hg19: chr8-12409110;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.